Ticker
Blood-clot risk from corona outweighs risk from vaccine
By EUobserver
A study of nearly 30 million people in England who received either the Oxford/AstraZeneca or the BioNTech/Pfizer vaccine indicates that the risk of blood clots after contracting coronavirus is many times larger than the risk presented by either vaccine, Politico reports. This effort is the largest study to look at this question, and was published in the British Medical Journal.